Smit, E; Crespo, C J; Semba, R D et al. (2006) Physical activity in a cohort of HIV-positive and HIV-negative injection drug users. AIDS Care 18:1040-5
|
Smit, Ellen; Semba, Richard D; Pilibosian, Erin et al. (2005) Body habitus in a cohort of HIV-seropositive and HIV-seronegative injection drug users. AIDS Patient Care STDS 19:19-30
|
Thio, C L; Nolt, K R; Astemborski, J et al. (2000) Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol 38:575-7
|
Tang, A M; Smit, E; Semba, R D et al. (2000) Improved antioxidant status among HIV-infected injecting drug users on potent antiretroviral therapy. J Acquir Immune Defic Syndr 23:321-6
|
Thomas, D L; Astemborski, J; Vlahov, D et al. (2000) Determinants of the quantity of hepatitis C virus RNA. J Infect Dis 181:844-51
|
Villano, S A; Vlahov, D; Nelson, K E et al. (1999) Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 29:908-14
|
Inglesby, T V; Rai, R; Astemborski, J et al. (1999) A prospective, community-based evaluation of liver enzymes in individuals with hepatitis C after drug use. Hepatology 29:590-6
|
Wang, Z; Lyles, C M; Beyrer, C et al. (1998) Diversification of subtype E human immunodeficiency virus type 1 env in heterosexual seroconverters from Northern Thailand. J Infect Dis 178:1507-11
|
Thomas, D L; Vlahov, D; Alter, H J et al. (1998) Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 177:539-42
|
Wang, Y M; Ray, S C; Laeyendecker, O et al. (1998) Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs. J Clin Microbiol 36:2982-9
|
Showing the most recent 10 out of 16 publications